Earnings wrap: AmSurg, Delek Logistics

Surgery center operator guides '14 below consensus; oil infrastructure owner more than doubles operating income
Feb 26, 2014 6:41 AM

Moderate raises for AmSurg execs

Quartet signs new employment agreements
Feb 6, 2014 1:01 PM

BlackRock builds AmSurg stake

Investment giant BlackRock likes the AmSurg story if its latest holdings report is anything go by. At the end of 2013, the firm owned 2.9 million shares of Nashville-based AmSurg, which amounts to 9 percent. A year ago — when AmSurg shares (Ticker: AMSG) were trading more than 30 percent lower than they are now — that stake was 7.8 percent.

Jan 29, 2014 12:18 PM

Analyst action: Delek, AmSurg

Deutsche Bank analyst Paul Sankey has upgraded his rating on shares of Delek US Holdings to 'buy' from 'hold' and hiked his price target to $40 from $30. Sankey, who also upgraded other refining plays, has grown more bullish on the company given the excess supply of light sweet crude. Investor sentiment toward refiners has swung in recent weeks, with Delek (Ticker: DK) popping 30 percent in the past month.

Over at Sidoti, analysts have begun covering shares of AmSurg with a 'neutral' rating and a price target of $48, about $2 above the company's Monday open. AmSurg (Ticker: AMSG) has risen 6 percent in the past month and is up more than 50 percent in 2013.

Dec 10, 2013 6:44 AM

Analyst action: NHI, AmSurg

Analysts at both Stifel Nicolaus and JMP Securities have hiked their rating on shares of National Health Investors to 'buy' from 'hold.' The JMP team now has a price target of $65 on the stock. The real estate investment trust is in the process of buying 25 properties for almost $500 million and both Stifel and JMP are helping manage a stock offering to help fund the deal. NHI shares (Ticker: NHI) ended Monday trading at $59.27 and are up slightly so far this year.

Over at Barclays, analysts have begun covering shares of ambulatory surgery center operator AmSurg. They have rated the stock 'equalweight' and see it climbing about 10 percent to $52. So far this year, AmSurg (Ticker: AMSG) is up more than 50 percent.

Nov 26, 2013 6:57 AM

AmSurg, Healthways execs active in their own stock

Surgery center execs cash in, wellness company officials step up after recent drop
Nov 14, 2013 2:29 PM

Report: Symbion on the block

Reuters says private-equity firm Crestview Partners is ready to cash in on its six-year-old investment in local ambulatory surgery center chain Symbion. The Burton Hills-based company could fetch as much as $800 million, sources say, which would be about 10 times its expected 2013 EBITDA. Through the first nine months of this year, Symbion posted operating income of $54.4 million, down 13 percent from a year ago.

Nov 12, 2013 5:59 AM

Earnings wrap: Capella, Emdeon, Symbion

Hospital chain's continuing operations break even, top line up 9% at revenue cycle manager, procedure levels flat at surgery center owner
Nov 11, 2013 7:00 AM

AmSurg hit with false claims suit

Nurse anesthetists allege California surgery centers skip steps
Nov 5, 2013 1:47 PM

Earnings wrap: AmSurg, Franklin Synergy

Surgery center chain ticks up guidance; community bank reports flat bottom line
Oct 23, 2013 1:20 PM